The impact of the number of CD34+ cells infused on the hematologic recovery after autologous peripheral blood stem cell (PBSC) transplantation.

被引：0
|
作者：
Palomera, L
Azaceta, G
Varo, MJ
Moreno, JA
Olave, T
Domingo, JM
Mayordomo, JI
Gutiérrez, M
机构：
[1] Clin Hosp, Dept Hematol, Zaragoza, Spain
[2] Clin Hosp, Dept Oncol, Zaragoza, Spain
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4310
引用
收藏
页码：304B / 304B
页数：1
相关论文
共 50 条
  • [11] Hematopoietic recovery in cancer patients after transplantation of autologous peripheral blood CD34+ cells or unmanipulated peripheral blood stem and progenitor cells
    Beguin, Y
    Baudoux, E
    Sautois, B
    Fraipont, V
    Schaaf-Lafontaine, N
    Pereira, M
    Paulus, JM
    Sondag, D
    Fillet, G
    TRANSFUSION, 1998, 38 (02) : 199 - 208
  • [12] Endogenous production of cytokines in autologous and allogeneic CD34+ selected peripheral blood stem cell transplantation.
    Vizcarra, E
    Solano, C
    Marugan, I
    Benet, I
    Arbona, C
    Gutiérrez, A
    García-Conde, J
    BONE MARROW TRANSPLANTATION, 1999, 23 : S82 - S82
  • [13] A higher number of infused CD34+ cells has a positive impact on the clinical outcome after related PBSC transplantation
    K Maie
    S Fuji
    K Tajima
    M Tatsuno
    S Yamagata
    N Takahashi
    R Ueda
    H Hashimoto
    K Takano
    Y Inoue
    A Ito
    Y Hayashi
    K Okinaka
    S Kurosawa
    S-W Kim
    R Tanosaki
    Y Heike
    T Yamashita
    T Fukuda
    Bone Marrow Transplantation, 2014, 49 : 1113 - 1115
  • [14] A higher number of infused CD34+ cells has a positive impact on the clinical outcome after related PBSC transplantation
    Maie, K.
    Fuji, S.
    Tajima, K.
    Tatsuno, M.
    Yamagata, S.
    Takahashi, N.
    Ueda, R.
    Hashimoto, H.
    Takano, K.
    Inoue, Y.
    Ito, A.
    Hayashi, Y.
    Okinaka, K.
    Kurosawa, S.
    Kim, S-W
    Tanosaki, R.
    Heike, Y.
    Yamashita, T.
    Fukuda, T.
    BONE MARROW TRANSPLANTATION, 2014, 49 (08) : 1113 - 1115
  • [15] Infections after autologous CD34 selected peripheral blood stem cell transplantation.
    Crippa, F
    Holmberg, L
    Hooper, H
    Carter, R
    Marr, K
    Bensinger, W
    Chauncey, T
    Corey, L
    Boeckh, M
    BLOOD, 2000, 96 (11) : 586A - +
  • [16] CD34+ selection of peripheral blood stem cells (PBSC) by an immunomagnetic method (Isolex 300, Baxter) for allogeneic transplantation.
    Martinez, C
    Canals, C
    Picon, M
    Brunet, S
    Sureda, A
    Cancelas, JA
    Garcia, J
    BLOOD, 1996, 88 (10) : 3682 - 3682
  • [17] Effect of CD34+ cell dose on hematopoietic reconstitution and outcome in 508 patients with multiple myeloma undergoing autologous peripheral blood stem cell (PBSC) transplantation.
    Klaus, J.
    CYTOTHERAPY, 2006, 8
  • [18] Apoptosis of CD34 positive peripheral blood stem cells (PBSC) and its role in hematopoietic recovery time after transplantation.
    Schoutteten, S
    Maloum, K
    Baudet, S
    Boccaccio, C
    Azar, N
    Sutton, L
    Leblond, V
    Merle-Beral, H
    BLOOD, 2000, 96 (11) : 318B - 319B
  • [19] What is the optimum number of CD34+ peripheral blood stem cells for an autologous transplant?
    Jillella, AP
    Ustun, C
    STEM CELLS AND DEVELOPMENT, 2004, 13 (06) : 598 - 606
  • [20] Varying of CD34+ cell quantities in peripheral blood after autologous transplantation of purge and unpurge stem cells.
    Wilhelm, S
    Leithäuser, M
    Kleine, HD
    Junghanss, C
    Freund, A
    Buthmann, U
    Cwienk, M
    Heussner, P
    Krammer-Steiner, B
    Casper, J
    Freund, M
    BLOOD, 1998, 92 (10) : 149B - 149B
12345